An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors von Abdelbaki, Mohamed S., DeWire Schottmiller, Mariko Dawn, Cripe, Timothy P., Curry, Richard C., Cruze, Charles A., Her, Leah, Demko, Suzanne, Casey, Denise, Setty, Bhuvana

Volltext

A pediatric and young adult phase I dose escalation study of BXQ-350 for solid and central nervous system tumors von Abdelbaki, Mohamed, Setty, Bhuvana, DeWire, Mariko Dawn, Cripe, Timothy P., Curry, Richard

Volltext

Next generation sequencing (NGS) to identify targetable recurring mutations and exceptional responders in relapsed and high-risk childhood and adolescent/young adult (AYA) malignan... von Turpin, Brian, Karns, Rebekah, Sarangdhar, Mayur, Weiss, Brian D., Geller, James I., Absalon, Michael, O'Brien, Maureen Megan, Nagarajan, Rajaram, Phillips, Christine L., Chow, Lionel M., DeWire, Mariko Dawn, Adams, Denise, Burns, Karen Cristly, Hummel, Trent Ryan, Fouladi, Maryam, Hammill, Adrienne Marie, Mangino, Jennifer, Pressey, Joseph Gerald, Aronow, Bruce, Perentesis, John Peter

Volltext